(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)
Secures over $200m funding to commercialise surgical robotic system: CMR Surgical
CMR Surgical has secured over $200 million in funding through a combination of equity and debt, aimed at accelerating the global commercialisation of its Versius Surgical Robotic System, with a strong focus on expanding in the US. The financing round, supported by existing investors, includes up to $68.75 million in growth capital from alternative asset manager Trinity Capital. Armentum Partners acted as financial adviser for the debt portion of the deal.
The funds will drive CMR’s growth strategy, product innovation, and the rollout of the upgraded Versius Plus system. Versius, which mimics the movement of a human arm for enhanced precision, has been used in more than 30,000 procedures across 30+ countries. It received FDA de novo clearance for adult cholecystectomy last year.
CMR is also advancing its clinical presence with two active trials—in paediatric surgery and transoral robotic surgery—highlighting the system’s versatility. The UK-based firm aims to make robotic minimal-access surgery more accessible and affordable.
08-04-2025